BRAVA CRT-D, BRAVA QUAD CRT-D, CONCERTO II CRT-D, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D, VIVA
FDA premarket approval P010031/S459 · decided 2014-08-13
Approval details
- PMA number
- P010031
- Supplement
- S459
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA CRT-D, BRAVA QUAD CRT-D, CONCERTO II CRT-D, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D, VIVA
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-08-01
- Decision date
- 2014-08-13
- Days to decision
- 12 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- USE A NEW SOFTWARE VERSION TO COLLECT MEASUREMENT AND PROCESS DATA AT THE HYBRID SUPPLIER.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.